Department of Health Care Finance (HT0) FY[removed]FY[removed]Agency Program Crosswalk OBP Agency Name FY 2013 Program

Source URL: cfo.dc.gov

For Immediate Release Ondine Announces Ventilator Associated Pneumonia (VAP) Photodisinfection Clinical Study in the US VANCOUVER, BC, May 10, 2011 – Ondine Biomedical Inc. (the “Company” or “Ondine”, TSX: OBP

Source URL: www.ondinebio.com

• Respiratory therapy
• Infectious diseases
• Pneumonia
• Ventilator-associated pneumonia
• Microbiology
• Nosocomial infection
• Biofilm
• Mechanical ventilation
• Antibiotic resistance
• Medicine
• Health
• Biology

For Immediate Release Ondine awarded QTDP Grant for Non-Antibiotic MRSA Decolonization Technology VANCOUVER, B.C. – November 4, 2010 – Ondine Biomedical Inc., formerly Ondine Biopharma Corporation, (TSX: OBP; AIM: O

Source URL: www.ondinebio.com

• Staphylococcaceae
• Bacterial diseases
• Antibiotic-resistant bacteria
• Methicillin-resistant Staphylococcus aureus
• Staphylococcus aureus
• Antibiotic resistance
• Nosocomial infection
• Staphylococcal infection
• Antimicrobial
• Bacteria
• Medicine
• Microbiology

For Immediate Release SUCCESSFUL MRSA WOUND DISINFECTION STUDY ANNOUNCED BY ONDINE Vancouver, Canada – March 12, [removed]Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) (the “Company”) today announced publication

Source URL: www.ondinebio.com

• Bacterial diseases
• Staphylococcaceae
• Antibiotic-resistant bacteria
• Methicillin-resistant Staphylococcus aureus
• Antibiotics
• Microbiology
• Antibiotic resistance
• Disinfectant
• Antimicrobial
• Health
• Biology
• Medicine

For Immediate Release Ondine Submits 510(k) Application to FDA for Periowave™ Gum Disease Treatment System Vancouver, Canada – October 1st, [removed]Ondine Biopharma Corporation (TSX: OBP; AIM: OBP), a medical technol

Source URL: www.ondinebio.com

• Bacterial diseases
• Staphylococcaceae
• Pathogenic bacteria
• Hygiene
• Methicillin-resistant Staphylococcus aureus
• Ondine
• Disinfectant
• Periodontitis
• Antibiotic resistance
• Bacteria
• Microbiology
• Medicine

For Immediate Release Ondine to Present at Canaccord Adams’ 28th Annual Global Growth Conference in Boston. Vancouver, Canada – Aug 6, [removed]Ondine Biopharma Corporation (TSX: OBP; AIM: OBP), a medical technology c

Source URL: www.ondinebio.com

• Literature
• Film
• Ondine
• Canaccord Adams
• Arts

For Immediate Release Ondine Expands MRSA Approvals with MRSAid™ Photodisinfection System VANCOUVER, BC, April 1, 2009 – Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) a medical technology company developing phot

Source URL: www.ondinebio.com

• Staphylococcaceae
• Bacterial diseases
• Antibiotics
• Antibiotic-resistant bacteria
• Methicillin-resistant Staphylococcus aureus
• Staphylococcus aureus
• Antibiotic resistance
• Nosocomial infection
• Antimicrobial
• Bacteria
• Medicine
• Microbiology

For Immediate Release Ondine Appoints Dr. Angelo Mariotti to Clinical Advisory Board Vancouver, Canada – October 29, 2007 – Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) a medical technology company developing p

Source URL: www.ondinebio.com

• Ondine
• Methicillin-resistant Staphylococcus aureus
• Periodontitis
• Biology
• Health
• Medicine
• Periodontology

For Immediate Release ONDINE COMPLETES SALE OF DENTAL BUSINESS Ondine to Focus on MRSA Product, MRSAid™ VANCOUVER, B.C. - June 8, 2009 – Ondine Biopharma Corporation (the “Company” or “Ondine”, TSX: OBP; AIM

Source URL: www.ondinebio.com

• Ondine
• Royalties
• Methicillin-resistant Staphylococcus aureus

Microsoft Word - OBP NR[removed]Final

Source URL: www.ondinebio.com

• Infectious diseases
• Catheters
• Antibiotic-resistant bacteria
• Methicillin-resistant Staphylococcus aureus
• Staphylococcaceae
• Nosocomial infection
• Urinary catheterization
• Urinary tract infection
• Biofilm
• Medicine
• Microbiology
• Biology